Dec. 9 (UPI) -- The U.S. Supreme Court declined to hear a case Monday that accused Purdue Pharma of moving billions of dollars in an effort to shield them from a spate of pending lawsuits over the popular opioid painkiller OxyContin.
The state argued in the suit Purdue and its owners, the Sackler family, has transferred about $6 billion over the past decade, which it says violates a fraud statute.